首页> 外文OA文献 >P62: DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA-RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY

【2h】

P62: DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA-RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY

机译：P62：Dupilumab在不受控制的中度至严重的哮喘患者中展示了每日哮喘相关症状的快速和持续改善：来自自由哮喘的哮喘的数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P62: DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA‐RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE‐TO‐SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY [J] . Internal medicine journal . 2018,第Suppla2期

机译：P62：Dupilumab在不受控制的中度至严重的哮喘的患者中表现出每日哮喘相关症状的快速和持续改善：来自自由哮喘探索研究的数据
2. DUPILUMAB REDUCES RISK OF SEVERE EXACERBATIONS AND IMPROVES FEV1 REGARDLESS OF BASELINE DISEASE SEVERITY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE PHASE 3 LIBERTY ASTHMA QUEST STUDY [J] . Pavord I., Papi A., Wenzel S., Thorax: The Journal of the British Thoracic Society . 2018,第Suppla4期

机译：Dupilumab降低严重恶化的风险，而改善FEV1，无论患者的基线疾病严重程度如何，不受控制的，中度至严重的哮喘：来自第3阶段自由哮喘的数据
3. Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study [J] . Yuji Tohda, Yoichi Nakamura, Takao Fujisawa, Allergology international: official journal of the Japanese Society of Allergology . 2020,第4期

机译：日本患者的杜帕米拉布疗效与安全，在3阶段哮喘哮喘患者中不受控制，中度至严重的哮喘患者
4. Liberty Asthma QUEST: Phase 3 Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled Moderate-to-Severe Asthma [O] . William W. Busse, Jorge F. Maspero, Klaus F. Rabe, -1

机译：自由性哮喘研究：3期随机双盲安慰剂对照平行组研究评估未控制中度至重度哮喘患者的Dupilumab疗效/安全性
5. Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study [O] . William W. Busse, Jorge F. Maspero, Nicola A. Hanania, 2019

机译：Dupilumab改善了肺功能，降低了在不受控制的，中度至严重的哮喘的患者中减少了严重的加剧率，或没有合并过敏性鼻炎：第3阶段自由哮喘寻求研究的结果

P62: DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA-RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY

著录项

引文网络

相似文献

相关主题

期刊订阅